Macrophage proteomic fingerprinting predicts HIV-1-associated cognitive impairment.
about
Proteomic profiling of cerebrospinal fluid identifies biomarkers for amyotrophic lateral sclerosisProteomics, biomarkers, and HIV-1: A current perspectiveProteomic fingerprints distinguish microglia, bone marrow, and spleen macrophage populations.Biomarker discovery in infectious diseases using SELDI.Differences in protein profiles of the isolates of Entamoeba histolytica and E. dispar by surface-enhanced laser desorption ionization time-of-flight mass spectrometry (SELDI-TOF MS) ProteinChip assays.Expression of monocyte markers in HIV-1 infected individuals with or without HIV associated dementia and normal controls in Bangkok Thailand.YKL-40, a marker of simian immunodeficiency virus encephalitis, modulates the biological activity of basic fibroblast growth factor.Characterization of the placental macrophage secretome: implications for antiviral activity.Proteomic analyses of monocyte-derived macrophages infected with human immunodeficiency virus type 1 primary isolates from Hispanic women with and without cognitive impairment.Nanomedicine in the diagnosis and therapy of neurodegenerative disorders.Proteomic analysis of HIV-infected macrophagesAntioxidant enzyme dysfunction in monocytes and CSF of Hispanic women with HIV-associated cognitive impairment.Insulin-like growth factor 2 receptor is an IFNgamma-inducible microglial protein that facilitates intracellular HIV replication: implications for HIV-induced neurocognitive disorders.Discovery and verification of amyotrophic lateral sclerosis biomarkers by proteomicsHIV-1 infection and AIDS: consequences for the central nervous system.Translational spatial task and its relationship to HIV-associated neurocognitive disorders and apolipoprotein E in HIV-seropositive women.The changing phenotype of microglia from homeostasis to diseaseCSF proteomic fingerprints for HIV-associated cognitive impairment.Cathepsin B and cystatin B in HIV-seropositive women are associated with infection and HIV-1-associated neurocognitive disorders.Neurocognitive disturbances in HIV.Biomarkers of HIV related central nervous system disease.NeuroAIDS: characteristics and diagnosis of the neurological complications of AIDS.Transcriptome analysis of HIV-infected peripheral blood monocytes: gene transcripts and networks associated with neurocognitive functioning.NanoART, neuroAIDS and CNS drug delivery.YWHAE/14-3-3ε: a potential novel genetic risk factor and CSF biomarker for HIV neurocognitive impairment.HIV/neuroAIDS biomarkers.Assessing health-related resiliency in HIV+ Latin women: Preliminary psychometric findings.Glutamate metabolism in HIV-infected macrophages: implications for the CNS.HIV-1 and the macrophage
P2860
Q24678722-91BE51E8-C032-4BA9-99E6-C7FB5E6EBCBDQ26853681-EF469D9C-380F-445C-9688-9E9DB7BF392AQ33213321-7DB2EFDC-D303-4B3B-A9BC-21B703F9B7B5Q33292219-056480C0-A013-4D61-86B7-E871C570D680Q33298509-1CD0AD2C-85DA-46CB-8DFD-60A1412C7542Q33314468-F7775E40-F680-484B-9A95-A4CA61BF9BDDQ33343967-972364DC-120B-4F59-9BA7-B614FDF8F79CQ33391778-C62A1D52-F1E2-4DA9-AAAD-8F1C8CB7354EQ33396476-D6B2D543-9FBB-4D20-ABE8-8E59C9B10EEEQ33726019-69938011-D466-4F0B-913D-6DE34C586D1AQ33770687-F9B0D60F-4503-40A1-B924-4855C4933010Q34164664-2E81C3D3-F462-4DF7-894C-8C1CE07E6A6BQ34254502-8D0B39F8-260D-4A33-B950-A60AC4F740E8Q34285662-0BCD3C9E-5F4D-4B58-BA7C-F077597EBC79Q36098879-AE4262F1-2604-4390-B623-ED86515CEB85Q36429120-497B935D-88B8-4025-9787-453E013DF4DEQ36444472-27D7123E-6864-48D1-98EB-9F2E4C2767CFQ36470218-C6F6C5D9-7421-4475-BC37-586E59B7E08DQ36670527-53F42221-7A8C-47BA-A8FA-5ECE140EF606Q37073656-ED42DF46-1857-453B-B48A-D6E1FD74E706Q37073672-4EE4CF7F-7B5B-43D9-A790-63C50940F565Q37089861-482DDF48-A5A9-4FBB-BEAD-FD27392776F4Q37374036-22B75F59-759A-4F18-B171-65096BF145E8Q37538776-B26D4667-F6BD-4969-844E-672F0DC6AF3AQ37657002-1722C79E-203E-4778-82E4-6D6DDB728E2AQ38809646-CCF560EF-C874-49E6-86C9-9AACD476EB08Q39309854-F3273CC6-2D62-4EDD-80CB-525942984CC9Q48546230-80B9F00F-D8ED-4B9A-B6F7-20EA31E5FC1AQ55967625-62D3F2B9-EEC0-47AE-983C-A96F809A4DFB
P2860
Macrophage proteomic fingerprinting predicts HIV-1-associated cognitive impairment.
description
2003 nî lūn-bûn
@nan
2003 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年学术文章
@wuu
2003年学术文章
@zh-cn
2003年学术文章
@zh-hans
2003年学术文章
@zh-my
2003年学术文章
@zh-sg
2003年學術文章
@yue
name
Macrophage proteomic fingerprinting predicts HIV-1-associated cognitive impairment.
@ast
Macrophage proteomic fingerprinting predicts HIV-1-associated cognitive impairment.
@en
type
label
Macrophage proteomic fingerprinting predicts HIV-1-associated cognitive impairment.
@ast
Macrophage proteomic fingerprinting predicts HIV-1-associated cognitive impairment.
@en
prefLabel
Macrophage proteomic fingerprinting predicts HIV-1-associated cognitive impairment.
@ast
Macrophage proteomic fingerprinting predicts HIV-1-associated cognitive impairment.
@en
P2093
P1433
P1476
Macrophage proteomic fingerprinting predicts HIV-1-associated cognitive impairment
@en
P2093
H E Gendelman
J Anderson
K A Carlson
L M Meléndez
T M Biskup
P304
P356
10.1212/01.WNL.0000064396.54554.26
P407
P577
2003-06-01T00:00:00Z